IPP Bureau
Johnson & Johnson appoints Dr. John Reed as EVP, Pharmaceuticals, R&D
By IPP Bureau - February 15, 2023
Univar Solutions expands ingredients portfolio through new distribution agreement with SI Group
By IPP Bureau - February 15, 2023
Strategic partnership aims to support significant growth of the Ibuprofen product market in Brazil and is backed by Univar Solutions' state-of-the-art Solution Center in São Paulo, Brazil
NATCO files generic Olaparib Tablets in USA
By IPP Bureau - February 14, 2023
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic, and prostate cancer
Infosys Foundation collaborates with Health Department of Karnataka
By IPP Bureau - February 14, 2023
Through this collaboration, the erstwhile Government Maternity Hospital in Kanakapura Taluk has been rebuilt and the new hospital has facilities including oxygen and medical gas pipelines
Thermo Fisher Scientific to introduce fully automated cell line automation platform
By IPP Bureau - February 14, 2023
Thermo Fisher and Celltrio bring first-in-kind automation platform to address critical scale-up challenges in biotherapeutics RoboCell cell line automation platform
FDA approves Pfizer's supplemental new drug application for CIBINQO
By IPP Bureau - February 14, 2023
Label expansion for CIBINQO provides new systemic oral option for adolescents (12 to <18 years) with moderate-to-severe atopic dermatitis
Sanofi announces change in R&D leadership
By IPP Bureau - February 14, 2023
Dr. Dietmar Berger, has agreed to take the leadership of the team ad interim
Govt. improving healthcare and medical education through holistic approach: Dr. Mandaviya
By IPP Bureau - February 13, 2023
Investment proposals to the tune of Rs. 54,000 crore has been received in the healthcare and Rs. 17,000 crore has been received in medical education sector
India committed to strengthen traditional medicine practice by bolstering evidence-based research: Sonowal
By IPP Bureau - February 13, 2023
The Ministry of Ayush endeavour is to get entry level NABH certification for 12,500 Ayush Wellness Centers by the end of 2023
Briefs: Biocon, Laurus Labs and Smruthi Organics
By IPP Bureau - February 13, 2023
Laurus Labs has announced that the USFDA completed inspection of the formulations manufacturing facility Unit-2, APSEZ, Atchutapuram, Visakhapatnam, Andhra Pradesh.
Johnson & Johnson MedTech India partners with Karkinos to upskill professionals in cancer care
By IPP Bureau - February 13, 2023
To bring quality cancer treatment closer to patients, India’s leading MedTech brand is joining forces with the unique technology-led platform
Global Hospital launches robotic surgery technology ‘Da Vinci Xi System’
By IPP Bureau - February 13, 2023
Sun Pharma Announces USFDA Approval for Generic Lenalidomide Capsules
By IPP Bureau - February 11, 2023
The respective product approval is based on Revlimid Capsules, 5mg, 10mg, 15mg, 25mg and 2.5mg, 20mg as a reference product
Glenmark Pharma reports Q3 FY 2022-23 revenue growth of 9.2%; PAT growth of 21.3%
By IPP Bureau - February 11, 2023
Profit After Tax (PAT) for the quarter ended December 31, 2022 was at Rs. 290.8 crore as compared to Rs. 239.8 crore in the previous corresponding quarter, registering a growth of 21.3% YoY
Dishman Carbogen Amcis Q3 FY23 revenue up 14%
By IPP Bureau - February 11, 2023
The company has announced net revenue of Rs. 639.8 crore for Q3 FY23 as compared to Rs. 562.08 crore in the corresponding period of the previous year
